Accession Number: | 0001493152-20-013478 |
Date: | 2020-07-15 |
Issuer: | PROVENTION BIO, INC. (PRVB) |
Original Submission Date: |
RAMOS ELEANOR
C/O PROVENTION BIO, INC., P.O. BOX 666
OLDWICK,, NJ 08858
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 12.62 | 2020-07-15 | deemed execution date | A | 137,750 (a) | 2030-07-15 | common stock, par value $0.0001 137,750 | $12.62 | 137,750 | direct |
ID | footnote |
---|---|
f1 | 55,100 option shares vest in four equal annual installments commencing on july 15, 2021; the remaining 82,650 options shares vest upon completion of certain performance milestones. the completion of each milestone vests 15% of the total option shares. |
f2 | the securities were granted pursuant to the issuer's amended and restated 2017 equity incentive plan. |